主要文件

查看所有文档

D2631

双十六烷基磷酸酯

Name: 双十六烷基磷酸酯
Brand: SIGMA

别名:

DHP, 磷酸二鲸蜡酯

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:

[CH₃(CH₂)₁₅O]₂P(O)OH

化学文摘社编号:

2197-63-9

分子量:

546.85

UNSPSC Code:

51191904

NACRES:

NA.25

PubChem Substance ID:

24893702

EC Number:

218-594-7

Beilstein/REAXYS Number:

1717117

MDL number:

MFCD00008999

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

description

anionic

Quality Level

100

form

powder

mol wt

546.85 g/mol

technique(s)

DNA extraction: suitable

mp

74-75 °C (lit.)

lipid type

phospholipids

storage temp.

−20°C

SMILES string

OP(OCCCCCCCCCCCCCCCC)(OCCCCCCCCCCCCCCCC)=O

InChI

1S/C32H67O4P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-35-37(33,34)36-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-32H2,1-2H3,(H,33,34)

InChI key

RNPXCFINMKSQPQ-UHFFFAOYSA-N

说明

Biochem/physiol Actions

磷酸二十六烷基酯（DHP）是带负电荷的脂质，用于形成模型膜。

存储类别

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

High-density lipoprotein mutant eye drops for the treatment of posterior eye diseases.

Kenji Suda et al.

Journal of controlled release : official journal of the Controlled Release Society, 266, 301-309 (2017-10-11)

Age-related macular degeneration (AMD), in which choroidal neovascularization (CNV) affects the center of the retina (macula), leads to the irreversible visual loss. The intravitreal injection of anti-angiogenesis antibodies improved the prognosis of AMD, but relatively less invasive therapies should be

A Novel Liposomal S-Propargyl-Cysteine: A Sustained Release of Hydrogen Sulfide Reducing Myocardial Fibrosis via TGF-β1/Smad Pathway.

Ba Hieu Tran et al.

International journal of nanomedicine, 14, 10061-10077 (2020-01-11)

S-propargyl-cysteine (SPRC; alternatively known as ZYZ-802) is a novel modulator of endogenous tissue H2S concentrations with known cardioprotective and anti-inflammatory effects. However, its rapid metabolism and excretion have limited its clinical application. To overcome these issues, we have developed some

Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery.

Hamdy Abdelkader et al.

Journal of pharmaceutical sciences, 100(5), 1833-1846 (2011-01-20)

This study aimed at preparing and evaluating Span 60-based niosomes for ocular delivery of naltrexone hydrochloride (NTX). Selected charged lipids [dicetyl phosphate (DCP) and stearyl amine (STA)] and surfactants [poly-24-oxyethylene cholesteryl ether (C24) and sodium cholate (CH)] were investigated as

查看所有相关文献

全球贸易项目编号

货号	GTIN
D2631-10G	04061833610442
D2631-5G	04061833610466
D2631-1G	04061833562499
D2631-25G	04061833610459